Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness

Eric Geijteman; Henning Tiemeier; Teun van Gelder

doi:10.1001/jamainternmed.2015.3997

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness

Erasmus MC Cancer Institute

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	1724-1725
Number of pages	2
Journal	JAMA Internal Medicine
Volume	175
Issue number	10
DOIs	https://doi.org/10.1001/jamainternmed.2015.3997
Publication status	Published - Oct 2015

Research programs

EMC MM-04-39-05
EMC NIHES-02-65-01
EMC NIHES-04-55-01
EMC OR-01-34-01

Access to Document

10.1001/jamainternmed.2015.3997

Cite this

@article{21169ae718a74fbebfa31c6d915b42c7,

title = "Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness",

author = "Eric Geijteman and Henning Tiemeier and \{van Gelder\}, Teun",

year = "2015",

month = oct,

doi = "10.1001/jamainternmed.2015.3997",

language = "English",

volume = "175",

pages = "1724--1725",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness

AU - Geijteman, Eric

AU - Tiemeier, Henning

AU - van Gelder, Teun

PY - 2015/10

Y1 - 2015/10

UR - https://www.scopus.com/pages/publications/84943545110

U2 - 10.1001/jamainternmed.2015.3997

DO - 10.1001/jamainternmed.2015.3997

M3 - Comment/Letter to the editor

C2 - 26436748

SN - 2168-6106

VL - 175

SP - 1724

EP - 1725

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 10

ER -

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness

Research programs

Access to Document

Other files and links

Cite this